Research
Education
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
Please note that all translations are automatically generated. Click here for the English version.
DOI :
10.3791/793-v
June 16th, 2008
Chapters
0:59
What are limitations of today's antiretroviral therapies
0:07
Title
1:41
Excision of proviral DNA. Targeting LTR specific sequences.
3:39
Addressing the problem of multiple HIV isolates.
4:35
Generation of site-specific Tre recombinase via directed molecular evolution.
5:49
Delivery of Tre recombinase, HIV-1 proviral DNA excision, and elimination of HIV-1 viruses.
6:39
Open questions.
8:21
Towards a clinical application.
현재 HIV - 1 전략은 바이러스 생활주기를 억제하지만, 효과적으로 감염을 근절하지 행동. 여기, 우리는 입증되는 감염된 세포의 게놈에서 설계 recombinase 수 효율적으로 소비세 통합 HIV - 1 proviral DNA.
Tags
-- Views
Related Videos
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit
Librarians
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
ABOUT JoVE
Leadership
Copyright © 2024 MyJoVE Corporation. All rights reserved